Artificial intelligence (AI) was, once again, the hottest investing topic in 2024. It might remain so in 2025, but that doesn't mean there aren't companies in other fields worth investing in. Consider two industries that also have excellent long-term prospects: e-commerce and cloud computing.

Nevertheless, growth stocks outperformed value stocks in 2024, and investors anticipate that trend will continue as the Federal Reserve cuts interest rates. Here are 10 of CFRA analysts' top growth stocks that have reported at least 15% annual revenue growth in the past three years:

It is no surprise that growth equities have found a place in the portfolios of some of the world's billionaire investors.

Dividend growth investing is a powerful strategy for long-term wealth creation. Companies that consistently raise their dividends demonstrate three crucial qualities: robust financial health, prudent management, and enduring competitive advantages. This winning combination has historically delivered superior returns over time.

Growth stocks have been helping propel the stock market higher for the past decade. Although the market has been off to a choppy start in 2025, there is good reason to believe that growth stocks can continue to lead it higher in the years ahead.

We recently compiled a list of the 12 Best Growth Stocks to Buy and Hold in 2025. In this article, we are going to take a look at where uniQure N.V.

But a pair of treatments that launched in 2019 are already offsetting Humira's losses. Combined sales of Skyrizi, a psoriasis treatment, and Rinvoq, for arthritis, soared to an annualized $19.3 billion in the third quarter.